MK

Mike Kramer

Partner at Vensana Capital

Santa Rosa, California

Overview

Work Experience

  • Partner

    2024 - Current

  • Venture Partner

    2021 - 2023

  • Board Member, Audit Committee Chair and Member of Compensation Committee

    2020 - 2024

  • Operating Partner

    2017 - 2021

  • Member of the Board of Directors

    2018 - 2020

  • Chief Operating Officer, Santa Rosa

    2016 - 2017

  • Chief Financial Officer

    2010 - 2016

    Cardiovascular device manufacturer focused on treatment of abdominal aortic aneurysms. Successfully completed a $91 million initial public offering in April 2014. Sold to Endologix in February 2016 for approximately $211 Million.

  • Chief Financial Officer

    2006 - 2010

    Public cardiovascular device manufacturer providing solutions for heart valve disease and atrial fibrillation. Sold to Medtronic in August 2010 for approximately $375 Million.

  • Controller

    2005 - 2006

    Public cardiac surgery company developing an artificial bypass graft for CABG surgery.

  • Manager, Financial Analysis

    2004 - 2005

  • Manager, Assurance and Advisory Services

    2001 - 2004

Relevant Websites